These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 12410087

  • 1. Clinical outcomes in juvenile dermatomyositis.
    Ramanan AV, Feldman BM.
    Curr Opin Rheumatol; 2002 Nov; 14(6):658-62. PubMed ID: 12410087
    [Abstract] [Full Text] [Related]

  • 2. Lipodystrophy and metabolic abnormalities in a case of adult dermatomyositis.
    Lee LA, Hobbs KF.
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S85-7. PubMed ID: 17938031
    [Abstract] [Full Text] [Related]

  • 3. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
    Wang A, Morgan GA, Paller AS, Pachman LM.
    J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
    [Abstract] [Full Text] [Related]

  • 4. Juvenile dermatomyositis.
    Batthish M, Feldman BM.
    Curr Rheumatol Rep; 2011 Jun; 13(3):216-24. PubMed ID: 21312074
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improvement of nailfold capillary microangiopathy after immunosuppressant therapy in a child with clinically amyopathic juvenile dermatomyositis.
    Campos LMA, Sallum AME, Camargo CZ, Andrade LEC, Kayser C.
    Rev Bras Reumatol Engl Ed; 2017 Jun; 57(5):487-490. PubMed ID: 29037322
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis.
    Nakamura H, Kawakami A, Ida H, Ejima E, Origuchi T, Eguchi K.
    J Rheumatol; 2006 Aug; 33(8):1691-3. PubMed ID: 16881125
    [Abstract] [Full Text] [Related]

  • 9. Successful immunosuppressive treatment of dermatomyositis: a nailfold capillaroscopy survey.
    Riccieri V, Vasile M, Macri V, Sciarra I, Stefanantoni K, De Luca N, Di Franco M, Spadaro A.
    J Rheumatol; 2010 Feb; 37(2):443-5. PubMed ID: 20147478
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Juvenile dermatomyositis forty years on: Case report.
    Rego de Figueiredo I, Guerreiro Castro S, Bernardino V, Silva Nunes J, Alves P, Moraes-Fontes MF.
    Neuromuscul Disord; 2018 Sep; 28(9):791-797. PubMed ID: 30064892
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.
    Ostrowski RA, Sullivan CL, Seshadri R, Morgan GA, Pachman LM.
    Arthritis Rheum; 2010 May; 62(5):1533-8. PubMed ID: 20213809
    [Abstract] [Full Text] [Related]

  • 16. Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.
    Arabshahi B, Silverman RA, Jones OY, Rider LG.
    J Pediatr; 2012 Mar; 160(3):520-2. PubMed ID: 22244459
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.
    Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP.
    Arthritis Rheum; 2009 Jun; 60(6):1825-1830. PubMed ID: 19479872
    [Abstract] [Full Text] [Related]

  • 20. Twelve years experience of juvenile dermatomyositis in North India.
    Singh S, Bansal A.
    Rheumatol Int; 2006 Apr; 26(6):510-5. PubMed ID: 16163542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.